课题基金 / 基金详情

Novel Approach to Peptide Therapy for Rheumatoid Arthritis

Novel Approach to Peptide Therapy for Rheumatoid Arthritis
肽治疗类风湿关节炎的新方法
批准号：
419073
负责人：
Barra Lillian
金额：
$66.88万
依托单位：
University of Western Ontario
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2020
资助国家：
加拿大
项目状态：
未结题
起止时间：
2020-03-01 至 2025-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=419073&lang=en
关键词：
Hla-Dr4 Human T Cell Responses Immune Responses To Citrullinated Antigens Immune Responses To Homocitrullinated Antigens Joint Histopathology Mouse Models Of Arthritis Peptide Treatment And Delivery Methods Pre-Clinical Imaging Pre-Clinical Locomo

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Rheumatoid Arthritis (RA) is a painful, chronic autoimmune disease that damages joints and causes disability. RA is the most common autoimmune inflammatory arthritis affecting >300,000 Canadians. There is no cure for RA and its cause is unknown. Currently
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金